Skip to main content
Premium Trial:

Request an Annual Quote

Caris Life Sciences Gets ISO 15189 Accreditation for Lab

NEW YORK (GenomeWeb News) – Caris Life Sciences today said that its tumor profiling lab in Phoenix, Ariz., has received ISO 15189 accreditation.

The accreditation was provided by the American Association for Laboratory Accreditation. The ISO 15189 standard covers qualifications and ongoing competency of the company's laboratory personnel, laboratory accommodation, equipment, reagents and supplies, pre-analytical and analytical factors, quality assurance considerations, and post-analytical factors, said Irving, Texas-based Caris.

The lab performs genomic testing associated with Caris Molecular Intelligence, the firm's tumor profiling service, which provides therapeutic guidance for up to 43 drug associations, "far exceeding the 12 that can be identified using next-generation sequencing alone," the firm said in a statement.

In addition to the ISO 15189 accreditation, the firm's lab also has a CLIA license, licenses from individual states including New York, and its biorepository has earned College of American Pathologists accreditation.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.